Physician

Chad Peterson, D.O.

According to 2025 Medicare claims, Chad Peterson, D.O. (NPI: 1821299751) practices dermatology in the Provo-Orem-Lehi, UT market, with the plurality of this provider's patient population coming from Utah, UT. This provider's primary affiliated billing organization is ASPEN DERMATOLOGY PLLC (NPI: 1407917107; TIN: 204009858) and primary practice location at 84651-1932.

Peterson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 509 traditional Medicare patients, billed 4,083 HCPCS/CPT codes, and received $350,162 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 644 prescription claims across 345 beneficiaries totaling $329,060 in drug costs, led by Betamethasone Dipropionate (Betamethasone Dipropionate). Open Payments data shows 48 records totaling $930. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $41,878 to $329,060. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$237K$475K2015 Medicare payment: $328,590 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $277,021 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $308,266 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $314,899 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $441,482 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $460,728 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $474,820 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $363,767 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $387,011 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $350,162 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157875,421$328,590
20168015,099$277,021
20178535,662$308,266
20188765,848$314,899
20197626,646$441,482
20206315,942$460,728
20216835,891$474,820
20226034,609$363,767
20235544,716$387,011
20245094,083$350,162

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$165K$329K2015 Drug cost: $41,878 (USD; Tot_Drug_Cst)2016 Drug cost: $92,245 (USD; Tot_Drug_Cst)2017 Drug cost: $140,024 (USD; Tot_Drug_Cst)2018 Drug cost: $95,221 (USD; Tot_Drug_Cst)2019 Drug cost: $117,955 (USD; Tot_Drug_Cst)2020 Drug cost: $79,809 (USD; Tot_Drug_Cst)2021 Drug cost: $106,510 (USD; Tot_Drug_Cst)2022 Drug cost: $139,476 (USD; Tot_Drug_Cst)2023 Drug cost: $327,146 (USD; Tot_Drug_Cst)2024 Drug cost: $329,060 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015275575$41,878
2016245574$92,245
2017333763$140,024
2018352715$95,221
2019349708$117,955
2020266566$79,809
2021332574$106,510
2022296542$139,476
2023317620$327,146
2024345644$329,060

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks119146$474
11102Biopsy of related skin growth, first growth145164$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more334512$60
17000Destruction of precancer skin growth, 1 growth242280$35
17003Destruction of precancer skin growth, 2-14 growths180877$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Betamethasone DipropionateBetamethasone Dipropionate631,344$2,412
FluorouracilFluorouracil26686$1,711
Clobetasol PropionateClobetasol Propionate24635$1,211
CephalexinCephalexin201982$971
Minocycline HclMinocycline Hcl361,200$962

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.48$930Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Chad Peterson, D.O.?

Tedicare shows public-source Medicare data for Chad Peterson, D.O. (NPI 1821299751), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chad Peterson, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Chad Peterson, D.O.?

Chad Peterson, D.O. is linked to ASPEN DERMATOLOGY PLLC (billing NPI 1407917107) in the available physician profile data.

Does Chad Peterson, D.O. have Open Payments data?

Chad Peterson, D.O. has 48 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.